ONE-WAYOngoing theme · still written in the latest filings
Government policy and institutional change risk for regenerative and cellular medicine and advanced medicine
Risk that changes to government policies promoting regenerative and cellular medicine and advanced medicine, institutional frameworks, or support policies will affect the adoption, research and development, and business plans of related businesses.
Companies1How many companies write about this.
Threads1One company can carry more than one thread here.
PeriodFY2017 →Still being written about.
Directionhurts0 helps · 1 hurts · 0 flat